The Food and Drug Administration is expected to quickly follow the recommendation and make J&J's shot the third vaccine authorised for emergency use in the US

India's drug regulator in July had granted market approval for the Pneumococcal Polysaccharide Conjugate vaccine, after reviewing the phase 1, 2 and 3 clinical trial data submitted by the Pune-based firm

Canadian PM Justin Trudeau said Canada would extend a 72-hour ban on passenger flights from Britain to Jan. 6, citing a new and more infectious variant of COVID-19

The Indian government is considering emergency use authorization for three vaccine candidates - one from AstraZeneca, another from Pfizer, and a separate one developed by the Indian firm Bharat Biotech

Union Health Ministry informed that the current cold chain system in India consists of 85,634 equipments for storage of vaccine at about 28,947 cold chain points across the country

Pfizer pledges commitment to engage with Indian government for vaccine provision; Aviation industry to lose Rs 21,000 crore in FY21; Only Saffola, MarkfedSohna, Nature's Nectar among 13 brands pass sugar syrup test, claims CSE. Watch this and more news on News Blast.

India Stock Market Highlights Today: Titan, followed by Sun Pharma, HDFC, ICICI Bank, Bajaj Finance, NTPC, HDFC Bank and M&M were among the major gainers on Sensex pack today. On the other hand, Tech Mahindra, HCL Tech, Kotak Bank, ITC and Bharti Airtel were among the laggards

Coronavirus vaccine news update: Serum Institute of India has been asked by Drug Controller General of India (DCGI) to change its protocol for Phase 2 and 3 trials of Oxford University-AstraZeneca COVID-19 vaccine

COVID 19 Vaccine News India: The government has now permitted a few relaxations to the Drugs and Cosmetics Act, 1940

Coronavirus vaccine update: The Canadian Center for Vaccinology at Dalhousie University has received the nod from Health Canada to begin clinical trials of the vaccine candidate

Coronavirus vaccine news: According to US media, thousands of doses of a potential virus for SARS have been sitting in a freezer in Houston since 2016 as the world lost interest in the disease